A Transferable IncC-IncX3 Hybrid Plasmid Cocarrying
<i>bla</i>
<sub>NDM-4</sub>
,
<i>tet</i>
(X), and
<i>tmexCD3-toprJ3</i>
Confers Resistance to Carbapenem and Tigecycline
Aki Hirabayashi,
Trung Duc Dao,
Taichiro Takemura,
Futoshi Hasebe,
Le Thi Trang,
Nguyen Ha Thanh,
Hoang Huy Tran,
Keigo Shibayama,
Ikuro Kasuga,
Masato Suzuki
Affiliations
Aki Hirabayashi
Antimicrobial Resistance Research Center, National Institute of Infectious Diseases, Tokyo, Japan
Trung Duc Dao
Vietnam Research Station, Center for Infectious Disease Research in Asia and Africa, Institute of Tropical Medicine, Nagasaki University, Nagasaki, Japan
Taichiro Takemura
Vietnam Research Station, Center for Infectious Disease Research in Asia and Africa, Institute of Tropical Medicine, Nagasaki University, Nagasaki, Japan
Futoshi Hasebe
Vietnam Research Station, Center for Infectious Disease Research in Asia and Africa, Institute of Tropical Medicine, Nagasaki University, Nagasaki, Japan
Le Thi Trang
National Institute of Hygiene and Epidemiology, Hanoi, Vietnam
Nguyen Ha Thanh
National Institute of Hygiene and Epidemiology, Hanoi, Vietnam
Hoang Huy Tran
National Institute of Hygiene and Epidemiology, Hanoi, Vietnam
Keigo Shibayama
Nagoya University Graduate School of Medicine, Nagoya, Japan
Ikuro Kasuga
Vietnam-Japan University, Vietnam National University, Hanoi, Vietnam
Tigecycline is important as a last-resort antimicrobial and effective against antimicrobial-resistant bacteria, such as carbapenem-producing EnterobacteralestettmexCD-toprJ
